Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study.

David J KuterJames B BusselWaleed GhanimaNichola CooperTerry GernsheimerMichele P LambertHoward A LiebmanMichael D TarantinoMichelle LeeHailing GuoAhmed Daak

Published in: Therapeutic advances in hematology (2023)

ClinicalTrials.gov NCT04562766: https://clinicaltrials.gov/ct2/show/NCT04562766; EU Clinical Trials Register EudraCT 2020-002063-60: https://www.clinicaltrialsregister.eu/ctr-search/search?query=2020-002063-60.

Keyphrases

phase iii
clinical trial
open label
double blind
phase ii
young adults
placebo controlled
computed tomography
physical activity
image quality
contrast enhanced
magnetic resonance
drug induced